Dual haemodialysis and haemodiafiltration blood treatment device
US RE50,004 In forceTerm ends Jan 15, 2036 · From the USPTO record
20-year base term ends Aug 13, 2034
Reissue of US 10,314,959, which was surrendered when this reissue was granted; its term and maintenance fees continue here.
Aug 13, 2014
Jan 15, 2036
Jun 11, 2024
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 13, 2014, when the earliest non-provisional application in its chain was filed (this one was filed Jun 11, 2021) | Aug 13, 2034 | USPTO record |
| Continuity chain | A reissue: its term follows the original patent's, with the original's term adjustment | follows the original patent | USPTO record |
| Patent term adjustment | +520 days, the original patent's USPTO patent term adjustment record, which governs a reissue (35 U.S.C. 251) | Jan 15, 2036 | USPTO record |
| Terminal disclaimer cap | None on record | no cap applied | USPTO record |
| Patent term extension | None on file | no change | USPTO record |
| Fee events | 1 of 3 maintenance fees paid | In force | USPTO record |
| Computed term end | The steps above, in order | Jan 15, 2036 | USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.